Exceptional Responders Initiative: Questions and Answers
NCI has embarked on the Exceptional Responders Initiative to understand the molecular underpinnings of exceptional responses to treatment, primarily via chemotherapy, in cancer patients.
Media Type: Html
- SourceUrl: https://www.cancer.gov/node/1085271/syndication
- Syndication ID: 16695
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Wednesday, May 17, 2017 at 05:10 PM
- Date Syndication Updated: Monday, August 05, 2019 at 07:40 PM
Tags
General:
response
feature
therapy
drug
DNA
molecular
gene
responders
ERI
exceptional
Embed Code Snippet
To get the embed code snippet please Login.
